Search Results 61-70 of 15716 for alt

1. Studying The Effect Of Levocarnitine In Protecting The Liver From Chemotherapy For Leukemia Or Lymphoma - Mayo Clinic

   * Serum glutamate pyruvate transaminase (SGPT) (ALT) =< 225 U/L (=< 5x ULN) (within 7 days prior to enrollment), and. * Note: For the purpose of this study ...

2. A Study Of MGL-3196 (Resmetirom) In Patients With MASH Who Have Undergone Liver Transplant For MASH Cirrhosis Or Other Etiologies - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) stability as defined by: Screening ALT and AST are within normal limits or show no ...

3. Mayo Clinic researchers identify link between gut bacteria and pre-clinical autoimmunity and aging in rheumatoid arthritis

   They published their findings in a recent study in Science Advances. This image has an empty alt attribute; its file name is MSS_0001342127.jpg- Veena ...

4. Hemochromatosis - Symptoms and causes - Mayo Clinic

   Hemochromatosis, also called primary or hereditary hemochromatosis, is the most common iron overload disease. It is a genetic condition that triggers the ...

5. A Study To Test The Efficacy, Safety, And Pharmacokinetics Of Rozanolixizumab In Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis - Mayo Clinic

   ... ALT, AST, or ALP up to 25 % above the exclusion limit (>2xULN) may be repeated once for confirmation. This includes rescreening. If any of the repeated tests ( ...

6. A Study to Evaluate Hepatotoxicity Risk Associated with TURALIO™ (pexidartinib) Treatment - Mayo Clinic

   AST or ALT > 3 × ULN with concurrent total bilirubin > 2 × ULN;; Isolated total bilirubin > 2 × ULN (excluding patients with Gilbert's syndrome);; Isolated ...

7. Efficacy And Safety Of GWP42003-P Oral Solution In Children With Epilepsy With Myoclonic-atonic Seizures - Mayo Clinic

   serum ALT or AST ≥ 3 × ULN with the presence of fatigue, nausea, vomiting, right upper quadrant pain or tenderness, fever, rash, and/or eosinophilia (> 5 ...

8. A Study To Evaluate ALN-6400 In Healthy Volunteers And Patients With Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

   * Has ALT or AST \>2×ULN * Has total bilirubin \>1.5×ULN * Has eGFR of \<30 mL/min/1.73m\^2 at screening. Parts A and B: * Is not willing to comply with the ...

9. Saroglitazar Magnesium For Treatment Of Primary Biliary Cholangitis - Mayo Clinic

   ALT or AST > 250 U/L 17. Participation in another interventional clinical study and receipt of any other investigational medication (within 12 weeks prior ...

10. Study Evaluating The Efficacy And Safety Of Obeticholic Acid In Subjects With Compensated Cirrhosis Due To Nonalcoholic Steatohepatitis - Mayo Clinic

    ALT ≥ 5 × ULN: If a third serum ALT measurement is required, and both Screening Visit 2 and unscheduled visit ALT values are ≥ 0% higher than the ...